BioCentury
ARTICLE | Company News

CeNeS acquires products from Glaxo

September 5, 2000 7:00 AM UTC

CeNeS (LSE:CEN) acquired from Glaxo (GLX; LSE:GLXO) rights in the U.K. and Ireland to three products: Diconal oral dipipanone analgesic combined with cyclizine, Cyclimorph intravenous morphine combine...